TY  - JOUR 
AU  - Nakamura, Toshifumi
AU  - Bonnard, Benjamin
AU  - Palacios-Ramirez, Roberto
AU  - Fernández-Celis, Amaya
AU  - Jaisser, Frédéric
AU  - López-Andrés, Natalia
PY  - 2022
SN  - 1422-0067
UR  - https://uvadoc.uva.es/handle/10324/66274
AB  - The beneficial effects of mineralocorticoid receptor (MR) antagonists (MRAs) for various kidney diseases are established. However, the underlying mechanisms of kidney injury induced by MR activation remain to be elucidated. We recently reported...
LA  - eng
PB  - MDPI
KW  - C-C motif chemokine ligand 3 (CCL3)
KW  - biglycan
KW  - glomerular injury
KW  - mineralocorticoid receptor
KW  - proteoglycan
KW  - toll-like receptor 4 (TLR4)
TI  - Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury
DO  - 10.3390/ijms23126680
ER  -